V Paul Doria-Rose

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey
    V Paul Doria-Rose
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 21:1049-59. 2012
  2. ncbi Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
    Lung Cancer 63:295-300. 2009
  3. ncbi Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Cancer 115:5007-17. 2009
  4. ncbi Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8574, USA
    Clin Trials 7:69-77. 2010
  5. ncbi The yield of surveillance colonoscopy by adenoma history and time to examination
    Paul F Pinsky
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Clin Gastroenterol Hepatol 7:86-92. 2009
  6. ncbi Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy
    Adeyinka O Laiyemo
    Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA
    Cancer Epidemiol 36:395-9. 2012

Collaborators

Detail Information

Publications6

  1. ncbi Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey
    V Paul Doria-Rose
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 21:1049-59. 2012
    ..The National Lung Screening Trial (NLST), which showed a 20% reduction in lung cancer mortality among those randomized to receive low-dose computed tomography (LDCT), will likely lead to increased screening use...
  2. ncbi Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
    Lung Cancer 63:295-300. 2009
    ..In these data, death certificates were sufficiently sensitive and specific such that their use did not result in a meaningful change to mortality-based outcomes...
  3. ncbi Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Cancer 115:5007-17. 2009
    ..However, these findings were based on incomplete follow-up, and each trial on its own was underpowered to detect a modest mortality benefit...
  4. ncbi Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials
    V Paul Doria-Rose
    Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8574, USA
    Clin Trials 7:69-77. 2010
    ..Often in randomized controlled trials of cancer screening, cause of death is determined by a mortality review committee. However, little is known regarding how findings from mortality review compare to those from death certificates alone...
  5. ncbi The yield of surveillance colonoscopy by adenoma history and time to examination
    Paul F Pinsky
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Clin Gastroenterol Hepatol 7:86-92. 2009
    ..Surveillance colonoscopy is recommended for subjects with a history of adenomas but there is limited information on the yield of surveillance...
  6. ncbi Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy
    Adeyinka O Laiyemo
    Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA
    Cancer Epidemiol 36:395-9. 2012
    ....